Skip to main content

Korean firm plans CDMO business

Hanmi Fine Chemical, an API manufacturing subsidiary of Hanmi Pharmaceutical, has announced plans for a new business offering what it calls ‘high-tech CDMO’ services. It will spend €7.4 million to build facilities for them and expects to form partnerships with more companies in 2H 2022, in addition to the ten it already has.

Azelis buys in France and Korea

Azelis has agreed to acquire Quimdis, a French distributor of ingredients for flavours and fragrances (F&F), animal nutrition, personal care, nutraceuticals, pharmaceuticals and food. Closing is expected to take place end of August. Terms were not disclosed. This company said that this strengthens it in “fast-growing and attractive markets, while also enhancing the position of Azelis France in the life science sector”.

Subscribe to South Korea